NIH has $144m to fund cancer nanotech R&D
Dr. Andrew von Eschenbach
Courtesy of National Cancer Institute
The National Cancer Institute plans to devote $144.3 million to a five-year initiative to develop and apply nanotechnology to cancer research.
'Nanotechnology has the potential to radically increase our options for prevention, diagnosis and treatment of cancer,' said Dr. Andrew von Eschenbach, director of the National Institutes of Health agency.
Nanotechnology, the development and engineering of devices so small they are measured on a molecular scale, has already demonstrated promising results in cancer research and treatment, he said.
NIH plans that the initiative, the NCI Alliance for Nanotechnology in Cancer, will integrate cancer-related nanotechnology research from public and private organizations and accelerate its application in clinical practice.
The National Cancer Institute will work with the National Institute of Standards and Technology to collaborate on standards and with the Food and Drug Administration to define the critical pathway for nanotechnologies to reach the clinic.
Mary Mosquera is a reporter for Federal Computer Week.